@bubsmark You’re good at asking questions that require speculation to answer. Because of this, irrespective of what I say you’ll see the negative and likely disagree.
whether we agree or not with ado’s strategy we’ve developed a high quality reader based test targeting specific market segments. This has been made clear since the outset. Our product solution is not targeting the at home market (the crapids have this covered here) surely you get this?
can we be successful in our targeted market is the big question, did we get the strategy completely wrong focussing on quality and the reader based platform? I choose to think not though I’m biased. FWIW.
- Forums
- ASX - By Stock
- ADO
- Ellume and Anteotech
Ellume and Anteotech, page-52
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $67.22M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 360700 | 2.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.4¢ | 865 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 360700 | 0.028 |
1 | 115000 | 0.027 |
7 | 1740000 | 0.025 |
6 | 634250 | 0.024 |
1 | 65217 | 0.023 |
Price($) | Vol. | No. |
---|---|---|
0.024 | 865 | 3 |
0.025 | 1758928 | 3 |
0.028 | 5555 | 1 |
0.029 | 4693635 | 4 |
0.030 | 1246950 | 5 |
Last trade - 13.01pm 12/11/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online